BioNTech Sues Moderna for Patent Infringement Over COVID Shots

Share!

Insurance Journal - Feb 20, 2026

German biopharmaceutical company BioNTech sued Moderna in Delaware federal court on Thursday, alleging that Moderna’s COVID-19 vaccine mNEXSPIKE infringes a patent related to BioNTech and Pfizer’s competing shot Comirnaty. The lawsuit said that mNEXSPIKE, Moderna’s next-generation...

Read Full Article

Recommended Articles

Reinsurance Rates Continued Softening During April Renewals, Despite Iran War

Posted: Apr 02, 2026

Reinsurance rates continued to soften during the April 1 renewals despite the unstable geopolitical...

Toymaker Hasbro Reports Cybersecurity Incident

Posted: Apr 02, 2026

Pawtucket, Rhode Island-based toymaker Hasbro, Inc. reported it is investigating a cybersecurity inc...

Mississippi Lawmakers Revive Wind-Mitigation Program with $15,000 Grants

Posted: Apr 02, 2026

Mississippi will soon become the latest state to provide wind-mitigation grants for homeowners if th...